“DEVELOPMENT OF NEW ANALYTICAL METHODS FOR THE ESTIMATION OF CILNIDIPINE IN BULK DRUG AND PHARMACEUTICAL FORMULATIONS”

M. Pharm Dissertation Protocol

Submitted to

RajivGandhiUniversity Of Health Sciences,

Bangalore, kARNATAKA

By

sravanthi gudavaRthi

Under the guidance of

Mr.PRAKASH S.SARSAMBIM.Pharm

DEPARTMENT OF PHARMACEUTICAL ANALYSIS

H.K.E.S’scollege of pharmacy,

SEDAM ROAD, GULBARGA – 585105

2010-2011

RAJIVGANDHIUNIVERSITY OF HEALTH SCIENCES, KARNATAKA, BANGALORE

ANNEXURE-II

PROFORMA FOR REGISTRATION OF SUBJECTS FOR DISSERTATION

1. / Name of the Candidate and
Address (in block letters) / SRAVANTHI GUDAVARTHI
D/O G.JANARDHAN RAO, FLAT NO:307, SUN RISE PARK APPARTMENTS, CZECH COLONY, STREET NO:3,SANATHNAGAR,HYDERABAD-500016, ANDHRA PRADESH.
2. / Name of the Institution / H.K.E.S’sCOLLEGE OF PHARMACY,Sedam Road, GULBARGA-585105, KARNATAKA.
3. / Course of Study and Subject / M. Pharm
(PHARMACEUTICAL ANALYSIS)
4. / Date of Admission to Course / 18-06-2010
5. / Title of the Research topic / “DEVELOPMENT OF NEW ANALYTICAL METHODS FOR THE ESTIMATION OF CILNIDIPINE IN BULK DRUG AND PHARMACEUTICAL FORMULATIONS”
6. / Brief Resume of Intended Work
6.1 Need for study
Cilnidipineis a new calcium channel blocker of the dihydropyridine type. It is used as antihypertensive. It is a dual blocker of L-type voltage gated calcium channels in vascular smooth muscle and N-type calcium channels in sympathetic nerve terminals that supply blood vessels, which makes it an efficient antihypertensive drug. It is not official in any pharmacopeia.And no spectrophotometric methods have been reported. Therefore Investigations of some new instrumental methods are in need for the quantitative estimation of cilnidipine in bulk drug and its pharmaceutical dosage forms with high sensitivity, accuracy, precision and economical too.
6.2 Review of Literature
Cilnidipine1-2 is chemically 1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 2-methoxyethyl (2E)-3-phenyl-2-propenyl ester. The Molecular formula for Cilnidipine is C27H28N2O7. Molecular weight is 492.5.Its melting point is 115.5-116.6oc. It is used in the treatment of hypertension. It is soluble in chloroform, acetone, slightly soluble in methanol, ethanol and water. Literature Survey reveals that few physico chemical methods are reported for Cilnidipine in plasma. i.e., HPTLC determination of Cilnidipine in pharmaceutical formulation3, LC-MS in plasma4,HPLC with tandem Mass spectroscopic detection in plasma5-6.The structural formula for Cilnidipine is as below

Cilnidipine
6.3 Objectives of the Study:
The analytical important function groups of Cilnidipine has not been completely exploited for designing sensitive, precise, accurate and flexible spectrophotometric methods for the determination of Cilnidipine in bulk drug and pharmaceutical formulations. Hence, with the above mentioned fact the following instrumental methods are planned to develop.
Since the drug Cilnidipine is sufficiently soluble in chloroform, acetone and slightly soluble in methanol, ethanol and water a number of UV spectrophotometric methods can be developed for its quantitative estimation in bulk drug and pharmaceutical dosage forms.
(i). Since Cilnidipine is having the aromatic nitro group which can be reduced to primary aromatic amino group with Zinc in HCl.

CILNIDIPINE (I) REDUCED CILNIDIPINE
I = R – NH2
Since, reduced cilnidipine (I) is having aromatic amino group it can be condensed with various aromatic aldehydeslike p-dimethylaminobenzaldehyde (PDAB) (II), p-dimethylamino cinnamaldehyde (PDACA) (III), vanillin to get coloredSciff’sbase and can be used for quantitative estimation of drug by visible spectrophotometry.

(I) (II)
Reduced Cilnidipine Colored chromogen or schiff’s base
7.


8. /

ii).Reduced Cilnidipine can be diazotised with nitrous acid (HNO2) and coupled with chromogenic agents like N-(1-naphthyl) ethelenediamine dihydrochloride (BMR) to get colored chromogens and drug can be estimated quantitatively by colorimetry.


Along with BMR reagent we can also use other coupling agents like -naphthol, diphenylamine, N-phenyl aniline, methyl aniline to developnumber of new analytical method.
iii). The amino group in reducedCilnidipine undergoes oxidative coupling reaction with 3-methyl-2-benzothiazolinone hydrazone (MBTH) in presence of Ferric Chloride or Cerric ammonium sulphate or Ferrous ammonium sulphate and forms the colored chromogen by which the drug can be estimated quantitatively by colorimetry.

iv).Reduced Cilnidipine forms colored complexes with 1,10-Phenanthroline and 2,2′-

bipyridine in presence of Fe (III) which can be utilized for quantitative estimation of

Cilnidipine in pharmaceutical formulations.


Colored chromogen Colored chromogen

v). Phosphomolybdo tungstic acid well known as Folin-ciocalteu(FC reagent) reagent in alkaline pH form colored chromogens with reduced Cilnidipine due to presence of aromatic amino group by redox reaction which can be used for quantitative estimation of Cilnidipine in bulk drug and its pharmaceutical dosage forms.

vi). ReducedCilnidipine forms colored internal salt with Citric acid in presence of acetic

anhydride which can be used for quantitative estimation of Cilnidipine in bulk drug and

Pharmaceutical dosage forms.

vii). Reduced Cilnidipine reacts with Ninhydrin reagent in N,N-dimethylformamide medium (DMF) producing colored product (Ruhemenn’s purple) which can be used for quantitative estimation of Cilnidipine in bulk drug and its pharmaceutical dosage forms.


Viii).Reduced Cilnidipine reacts with p-benzoquinone (PBQ) to form colored product which can be used quantitatively for estimation of Cilnidipine in bulk and pure forms.


ix).Reversed phase HPLC method can also be developed using (shimadzu HPLC class VP series 6.01 ) with two LC-10 AT VP pumps variable wave length programmable UV/Visible detector for quantitative estimation of Cilnidipine in bulk drug and pharmaceutical dosage forms with high accuracy, sensitivity, precision too.
Material and Methods
In the present investigation of new Instrumentalmethods for quantitative estimation ofCilnidipine, we are in need and using Shimadzu 1700 double beam UV/visible spectrophotometer, HPLC (Shimadzu class VP series 6.01), chromatographic instruments and volumetric glass apparatus. Drug sample will be provided by J.B Chemicalspharmaceuticals Ltd, Daman–396210.
7.1 Source of Data

1.Internet, Library

  1. GulbargaUniversity, Gulbarga
  2. I.I.Sc. Library, Bangalore
  3. I.I.C.T. Library, Hyderabad
  4. R.G.U.H.S. Library, Bangalore
7.2 Methods of Collection of Data (including sampling procedure, if any)

Data collected from

  1. Internet, H.K.E.S. College of Pharmacy, Gulbarga.
  2. Analytical abstract and chemical abstract GulbargaUniversity, I.I.C.T. & I.I.SC. Libraries.
  3. Journals like – Indian J. Pharmaceutical Sciences, Indian Drug, Indian J. Analytical Chemistry, Pharma review and Asian .J.Chemistry.
  4. e-Journals
  5. Drug sample of Cilnidipine will be collected fromJ.B. Chemicalspharmaceuticals Ltd,Daman-396210.
7.3 Does study require any investigation or interventions to be conducted on patients or other humans or animals? If so please describe briefly

-No-

7.4 Has ethical clearance been obtained from your institution in case of 7.3

-Not Applicable-

References
  1. O’Neil M.J, editor, The Merck Index An Encyclopedia of Chemicals, Drugs and Biologicals, Merck & Co. Inc. 14th edition, 2006: 379.
  1. Sweetman SC, editor, Martindale The Complete Drug Reference, Pharmaceutical Press, London (U.K), 35th edition,2007:1118.
  1. Karmalkar HS, Vaidya VV, Gomes NA, Chooukekar MP and Kekare MB. Determination of cilnidipine from pharmaceutical formulation by high performance thin layer chromatographic method. Analytical chemistry 2008; 7(8).
  1. Hatada K, Kimura M, Ono L and Ozaki M. Determination of a new calcium antagonist and its main metabolite in plasma by thermospray liquid chromatography – mass spectroscopy. J Chromaogr. 1992; 583: 116-121.
  1. Xianhua zhang.Determination of Cilnidipine, a new calcium antagonist, in human plasma using high performance liquid chromatography with tandem mass spectroscopic detection. Analyticalchemical acta. 2007; 142-146.
  1. Lee HW, Seo JH, Lee HS, Jeong SYand Lee KT. Development of a liquid chromatography/ negative ion electrospray tandem mass spectrometry for the determination of cilnidipine in human plasma and its application to bioequivalence study. J Chromatogr B Analyt Technol Biomed Life Sci. 2008; 862: 246-51.

9. / Signature of Candidate
10. / Remarks of the Guide / The work undertaken will be novel & Industrial oriented. The work will be new research findings. All facilities are available in our college to undertake the work.
11. / Name & Designation of (in blockletters)
11.1Guide
11.2Signature / Mr.PRAKASHS.SARSAMBI,M.PharmASSISTANT PROFESSOR
DEPT. OF PHARMACEUTICAL ANALYSIS,
H.K.E.S’sCOLLEGE OF PHARMACY,
GULBARGA.
11.3Head of the Department
11.4Signature / Dr. S.M.MALIPATIL M.Pharm., Ph.D
PROFESSOR
DEPT. OF PHARMACEUTICAL ANALYSIS,
H.K.E.S’sCOLLEGE OF PHARMACY,
GULBARGA.
12 / 12.1Remarks of the Chairman & Principal
12.2 Signature